Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Cannabinoids may help treat various skin conditions.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Tissue engineering could be a future solution for hair loss, but it's currently expensive, complex, and hard to apply in real-world treatments.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Capsaicin, found in chili peppers, can slow down hair growth by affecting skin cells and hair follicles.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

FOXN1 gene variants cause low T cells and immune issues from birth.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

Hair follicle stem cells help maintain skin health and could improve skin replacement therapies.

High mTORC1 activity slows hair growth and causes it to lose color.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.